Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05713149

Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents

Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents in Patients Patients With Neuromotor Disability : a Prospective Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Institut de Sante Parasport Connecte Synergies · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

People with neuromotor disability (i.e. following an inborn or acquired spinal cord, cerebral or peripheral neurological lesion) are at high risk of osteomyelitis-associated pressure ulcers. The management of osteomyelitis-associated pressure ulcers is controversial. In our center, patients benefit from a one stage surgical management with bone shaving and flap covering osteitis of pressure ulcer to perform wound closing. Surgery is followed by an antibiotic treatment, secondarily adapted to intraoperative samples. The aim of this study is to describe the cohort and to identify factors associated with failure (or success) in this frail population.

Detailed description

This is a prospective, monocentric, cohort study of neurological disabled inpatients subjects treated in the perioperative disability unit (UPOH) of our university hospital for osteomyelitis-associated pressure ulcer by surgical flaps and anti bacterial agents. All eligible inpatient subjects with neuromotor disability and admitted for the treatment of osteomyelitis-associated pressure ulcers by surgical flaps will be consecutively included. Patients are followed up in consultation at 30 or 45 days after surgery, and in consultation or teleconsultation at 12 months after surgery. Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological, and physiological examinations. Data related to sitting, nutrition, spasticity, bladder and bowel disorders, bacteriological sampling and antibiotic treatments will be collected. This is a routine care study; no procedures are added for research purposes. It is an ancillary study to the NO-AGING study.

Conditions

Interventions

TypeNameDescription
OTHERSurgical flap and anti-bacterial agentsSurgical flap and anti-bacterial agents

Timeline

Start date
2023-02-19
Primary completion
2026-02-01
Completion
2027-02-01
First posted
2023-02-06
Last updated
2023-02-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05713149. Inclusion in this directory is not an endorsement.